Health · 2 views
Patient Death Reported in Multiple Sclerosis CAR-T Study
(MedPage Today) -- The investigational CD19-directed chimeric antigen receptor (CAR) T-cell therapy zolacabtagene autoleucel (zola-cel) showed the potential to treat people with highly active relapsing multiple sclerosis (MS) and…
Summary
(MedPage Today) -- The investigational CD19-directed chimeric antigen receptor (CAR) T-cell therapy zolacabtagene autoleucel (zola-cel) showed the potential to treat people with highly active relapsing multiple sclerosis (MS) and progressive MS
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedCoverage Context
More from Health
Continue reading recent Health coverage
- Atacicpet, Sibeprenlimab Halt Decline in Kidney Function in IgA NephropathyContinue reading
- Ultrasonic technology enables earlier stress-fracture detectionContinue reading
- RSV Hospitalization May Be Taking a Surprising Mortality Toll, CDC FindsContinue reading
- Clinician AI Use; Predicting Bad Infant Outcomes in Labor; Donor Heart DistributionContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow